Neurology Medical News about Diabetic Neuropathies Peripheral Nerves Peripheral Nervous System Diseases

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review
Journal of Diabetes and its Complications, 09/23/09

Schemmel KE et al. – Given the mechanism by which diabetic peripheral neuropathy can result, targeting the polyol pathway as a method of treatment appears promising, yet the efficacy of newer AR inhibitors is still to be proven. Currently, these agents are not marketed in the United States. As newer studies emerge, diabetes educators will learn more about their efficacy and safety in preventing and treating diabetic peripheral neuropathy.

<< Previous
The anterior insula in autism: Under-connected and under-examined

Next >>
Meta-Analysis of Apparent Diffusion Coefficients in the Newborn...